Misuse of Drugs (Classification of Tapentadol) Order Commencement Order 2012

2012/41

Coat of Arms of New Zealand

Misuse of Drugs (Classification of Tapentadol) Order Commencement Order 2012

Jerry Mateparae, Governor-General

Order in Council

At Wellington this 26th day of March 2012

Present:
His Excellency the Governor-General in Council

Pursuant to section 4A(1) of the Misuse of Drugs Act 1975 and a resolution of the House of Representatives made on 1 March 2012 in accordance with section 4A(3) of that Act, His Excellency the Governor-General, acting on the advice and with the consent of the Executive Council, makes the following order.

Order

1  Title
  • This order is the Misuse of Drugs (Classification of Tapentadol) Order Commencement Order 2012.

2  Commencement of Misuse of Drugs (Classification of Tapentadol) Order 2011

Rebecca Kitteridge,
Clerk of the Executive Council.


Explanatory note

This note is not part of the order, but is intended to indicate its general effect.

This order brings the Misuse of Drugs (Classification of Tapentadol) Order 2011 into force on 1 May 2012. That order adds tapentadol (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]phenol hydrochloride), which is to be classified as a class B3 controlled drug, to Part 3 of Schedule 2 of the Misuse of Drugs Act 1975.

Under section 4A(2) of the Misuse of Drugs Act 1975, this commencement order may be made only after the Misuse of Drugs (Classification of Tapentadol) Order 2011 has been approved by resolution of the House of Representatives. The House of Representatives approved that order on 1 March 2012.


Issued under the authority of the Acts and Regulations Publication Act 1989.

Date of notification in Gazette: 29 March 2012.

This order is administered by the Ministry of Health.